BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 38192931)

  • 1. Liquid Biopsy: An Evolving Paradigm for Non-invasive Disease Diagnosis and Monitoring in Medicine.
    Adhit KK; Wanjari A; Menon S; K S
    Cureus; 2023 Dec; 15(12):e50176. PubMed ID: 38192931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy for precision diagnostics and therapeutics.
    Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
    Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy based biomarkers in non-small cell lung cancer for diagnosis and treatment monitoring.
    Pérez-Callejo D; Romero A; Provencio M; Torrente M
    Transl Lung Cancer Res; 2016 Oct; 5(5):455-465. PubMed ID: 27826527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.
    Reina C; Šabanović B; Lazzari C; Gregorc V; Heeschen C
    Transl Res; 2024 Jun; 272():41-53. PubMed ID: 38838851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer.
    Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J
    Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
    Huang Z; Fu Y; Yang H; Zhou Y; Shi M; Li Q; Liu W; Liang J; Zhu L; Qin S; Hong H; Liu Y
    Mol Cancer; 2024 Feb; 23(1):36. PubMed ID: 38365716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy.
    Liu S; Wang J
    Curr Issues Mol Biol; 2022 Jun; 44(6):2695-2709. PubMed ID: 35735625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management.
    Elazezy M; Joosse SA
    Comput Struct Biotechnol J; 2018; 16():370-378. PubMed ID: 30364656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA).
    Lim M; Kim CJ; Sunkara V; Kim MH; Cho YK
    Micromachines (Basel); 2018 Feb; 9(3):. PubMed ID: 30424034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
    Zhang X; Ju S; Wang X; Cong H
    Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
    Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
    J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA.
    Yaghoubi Naei V; Bordhan P; Mirakhorli F; Khorrami M; Shrestha J; Nazari H; Kulasinghe A; Ebrahimi Warkiani M
    Ther Adv Med Oncol; 2023; 15():17588359231192401. PubMed ID: 37692363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
    Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
    Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.